<SEC-DOCUMENT>0001472595-15-000079.txt : 20150724
<SEC-HEADER>0001472595-15-000079.hdr.sgml : 20150724
<ACCEPTANCE-DATETIME>20150724080417
ACCESSION NUMBER:		0001472595-15-000079
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20150724
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20150724
DATE AS OF CHANGE:		20150724

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Accretive Health, Inc.
		CENTRAL INDEX KEY:			0001472595
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MANAGEMENT SERVICES [8741]
		IRS NUMBER:				020698101
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34746
		FILM NUMBER:		151003447

	BUSINESS ADDRESS:	
		STREET 1:		401 NORTH MICHIGAN AVENUE
		STREET 2:		SUITE 2700
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60611
		BUSINESS PHONE:		312-324-7820

	MAIL ADDRESS:	
		STREET 1:		401 NORTH MICHIGAN AVENUE
		STREET 2:		SUITE 2700
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60611
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>item801july242015gs.htm
<DESCRIPTION>8-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2015 Workiva -->
		<title>Item 8.01 July 24, 2015 GS</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<a name="sE8FABDDCE3D6F4569BE4BCCA804F998A"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-top:4px;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">UNITED STATES</font></div><div style="line-height:120%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">WASHINGTON, D.C. 20549</font></div><div style="line-height:120%;padding-top:5px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:5px;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font><font style="font-family:inherit;font-size:18pt;font-weight:bold;">FORM 8-K</font></div><div style="line-height:120%;padding-top:5px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">CURRENT REPORT</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Pursuant to Section&#160;13 or 15(d) of the</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Securities Exchange Act of 1934</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Date of Report (Date of earliest event reported): July 24, 2015</font></div><div style="line-height:120%;padding-top:5px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;padding-top:6px;text-align:center;font-size:24pt;"><font style="font-family:inherit;font-size:24pt;font-weight:bold;">Accretive Health, Inc.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Exact Name of Registrant as Specified in Charter)</font></div><div style="line-height:120%;padding-top:5px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.6015625%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td width="32%"></td><td width="3%"></td><td width="31%"></td><td width="3%"></td><td width="31%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Delaware</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">001-34746</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">02-0698101</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(State or Other Jurisdiction</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">of Incorporation)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Commission</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">File Number)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(IRS Employer</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Identification No.)</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:84.1796875%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td width="22%"></td><td width="23%"></td><td width="24%"></td><td width="3%"></td><td width="28%"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">401 North Michigan Avenue, Suite&#160;2700, Chicago, Illinois</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">60611</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Address of Principal Executive Offices)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Zip Code)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Registrant&#8217;s telephone number, including area code: (312)&#160;324-7820</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Former Name or Former Address, if Changed Since Last Report)</font></div><div style="line-height:120%;padding-top:5px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="6%"></td><td width="94%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</font></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="6%"></td><td width="94%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="6%"></td><td width="94%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule&#160;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="6%"></td><td width="94%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule&#160;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></div><hr style="page-break-after:always"><a name="sE061D7FCB2C1F4639347BCCA807E3B48"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 8.01. Other Events</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On July 24, 2015, Accretive Health, Inc. announced that its Board of Directors has retained Goldman, Sachs &amp; Co., to serve as financial advisor to the Company and to assist the Board in its evaluation of potential strategic alternatives.&#160; A copy of the press release is attached as Exhibit 99.1 and incorporated herein by reference.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 9.01 Financial Statements and Exhibits</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exhibits</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></div><hr style="page-break-after:always"><a name="sF6E4C8E56DF631A97BB8BCCA809D3EB3"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURES</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td width="38%"></td><td width="6%"></td><td width="3%"></td><td width="5%"></td><td width="3%"></td><td width="45%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ACCRETIVE HEALTH, INC.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date: July 24, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/  Peter P. Csapo</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:  Peter P. Csapo</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:    Chief Financial Officer and Treasurer</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></div><hr style="page-break-after:always"><a name="sbf869e75c3f845a9b17fb6a7abb70fd5"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EXHIBIT INDEX</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Exhibit Number</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Description of Exhibit</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Press release issued by Accretive Health, Inc. dated July 24, 2015</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex991-pressreleasedatedjul.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2015 Workiva -->
		<title>Ex 99.1 - Press release dated July 24, 2015</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<a name="s8ab25110359d42408c2865f4eca54774"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:174%;text-align:left;"><img src="logo.jpg" style="height:53px;width:290px;"></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accretive Health Retains Goldman, Sachs &amp; Co. as Financial Advisor</font></div><div style="line-height:232%;text-align:left;padding-left:101px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CHICAGO - July 24, 2015 -</font><font style="font-family:inherit;font-size:10pt;">&#32;Accretive Health, Inc. (OTC Pink: ACHI) today announced that its Board of Directors has retained Goldman, Sachs &amp; Co., to serve as financial advisor to the Company and to </font><font style="font-family:inherit;font-size:10pt;color:#252525;">assist the Board in its evaluation of potential strategic alternatives</font><font style="font-family:inherit;font-size:10pt;">.  Accretive announced on July 16, 2015 that its Board had</font><font style="font-family:inherit;font-size:10pt;color:#252525;">&#32;resolved to undertake a review of strategic alternatives to enhance stockholder value. While the review is ongoing, the Company&#8217;s strengthened management team will continue to focus on a number of strategic and operational initiatives intended to drive the Company&#8217;s long term growth and financial performance. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#252525;">The Company has not made a decision to pursue any specific strategic transaction or any other strategic alternative. There can be no assurance that the exploration of strategic alternatives will result in the completion of any transaction or other alternative. The Company has not set a timetable for completion of the evaluation process, and it does not expect to comment further unless and until its board of directors has approved a specific transaction, or it otherwise deems further disclosure is appropriate or required by law. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#252525;">As previously announced, the Company also has retained Kirkland &amp; Ellis LLP, as its legal advisor. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Safe Harbor</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This press release contains forward-looking statements, including the statements regarding the plans, strategies and objectives of management for future operations, effects of current or future economic conditions or performance and industry trends and other matters that do not relate strictly to historical facts or statements of assumptions underlying any of the foregoing. All forward-looking statements contained in this press release involve risks and uncertainties. The Company&#8217;s actual results and outcomes could differ materially from those anticipated in these forward-looking statements as a result of various factors, including the factors set forth in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2014, filed with the SEC on June 23, 2015, under the heading &#8220;Risk Factors&#8221;. The words &#8220;strive,&#8221; &#8220;objective,&#8221; &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;may,&#8221; &#8220;plans,&#8221; &#8220;projects,&#8221; &#8220;vision,&#8221; &#8220;would,&#8221; and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The Company has based these forward-looking statements on its current expectations and projections about future events. Although the Company believes that the expectations underlying any of its forward-looking statements are reasonable, these expectations may prove to be incorrect and all of these statements are subject to risks and uncertainties. Should one or more of these risks and uncertainties materialize, or should underlying assumptions, projections, or expectations prove incorrect, actual results, performance, financial condition, or events may vary materially and adversely from those anticipated, estimated, or expected. </font></div><div style="line-height:120%;padding-bottom:16px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All forward-looking statements included in this press release are expressly qualified in their entirety by these cautionary statements. The Company cautions readers not to place undue reliance on any forward-looking statement that speaks only as of the date made and to recognize that forward-looking statements are predictions of future results, which may not occur as anticipated. Actual results could differ materially from those anticipated in the forward-looking statements and from historical results, due to the uncertainties and factors described above, as well as others that the Company may consider immaterial or does not anticipate at this time. Although the Company believes that the expectations reflected in its forward-looking statements are reasonable, the Company does not know whether its expectations may prove correct. The Company&#8217;s expectations reflected in its forward-looking statements can be affected by inaccurate assumptions it might make or by known or unknown uncertainties and factors, including those described above. The risks and uncertainties described above are not exclusive, and further information concerning the Company and its business, including factors that potentially could materially affect its financial results or condition or relationships with customers and potential customers, may emerge from time to </font></div><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></div><hr style="page-break-after:always"><a name="s8ab25110359d42408c2865f4eca54774"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-bottom:16px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">time. The Company assumes no, and it specifically disclaims any, obligation to update, amend, or clarify forward-looking statements to reflect actual results or changes in factors or assumptions affecting such forward-looking statements. The Company advises investors, however, to consult any further disclosures it makes on related subjects in our periodic reports that it files with or furnishes to the SEC. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">About Accretive Health</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At Accretive Health, our mission is to partner with healthcare communities to serve as a catalyst for a healthier future for all.  For more information, visit www.accretivehealth.com.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Contact:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accretive Health, Inc.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investor and Media Relations:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Atif Rahim</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">312.324.5476</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#0000ff;text-decoration:underline;">investorrelations@accretivehealth.com</font></div><div style="line-height:120%;padding-bottom:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo.jpg
<TEXT>
begin 644 logo.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!:17AI9@``34T`*@````@`!0,!``4`
M```!````2@,#``$````!`````%$0``$````!`0```%$1``0````!```.PU$2
M``0````!```.PP```````8:@``"QC__;`$,``@$!`@$!`@("`@("`@(#!0,#
M`P,#!@0$`P4'!@<'!P8'!P@)"PD("`H(!P<*#0H*"PP,#`P'"0X/#0P."PP,
M#/_;`$,!`@("`P,#!@,#!@P(!P@,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#/_``!$(`#\!4`,!(@`"$0$#$0'_
MQ``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_Q`"U$``"`0,#`@0#
M!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*"
M"0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS
M='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$
MQ<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q``?`0`#`0$!
M`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($!`,$!P4$!``!`G<`
M`0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$``A$#$0`_`/W\HHHH
M`****`"BO$_VY?VX?#G["?P]T+Q#XB@FO8=:UNVTH00,/.2)B6GN`O\`$(HE
M9RO<[5R"PKV#P]X@LO%F@66J:9=07VG:E`EU:W,#AX[B)U#(ZD<$%2"#[UM*
MA4C3C5DO=E>S]-Q75[%RBBBL1A1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!7#_$KXXZ;X`^(?@SPBNV[\2>-KR2*RLU;#);01F6YNG](XT`7/=Y8U[\:7
MQC^+N@_`7X7ZWXP\3WJZ?H7A^U:[NYCR=HZ*H_B=F(55')9@!UK\[O\`@F=\
M?M1_:C_:C^./[2OC8&VTCP;H']F:5:,VY-'LR7N7A0]-PB@4NP^\TS'H17IX
M++Y5:53$2^&"^^3T2^]W?EZD2G9J)X-_P7L_:+/Q:_;"@\'6EQYFD_#>Q6U9
M5;*&^N`LLY^JIY">Q5J]@_X(0?M]2Z2MK\%/&-Q+'97K2R>"M0N05BD=<O/I
MRN>&(Y=`#Q\Z?W!7S%^S'\`[+]JCQ+X[^/OQGO[G1?A1I.ISZKKERI*W&OWT
MTGF+IUMC!)RZ*Q7D9500263[3_86_:CM/VX_AE\8HM;\#^&/#7PP^%^G6T_A
M'3+.T43^'V2.ZD$RS_PW"B*-P\878PXSR3]OF-.C3R[ZDH<RII<S[2?;N[N[
M79[ZG+!MSYNY^C5%?-/_``2U_;QM?VZOV<;/4;UX8?&_A]([+Q':+A?WVWY+
ME%_YYS`%AZ,'7^&OI:OSS$X:IAZLJ-56E$[(R4E=!6#'\4O#,WC]_"B^(=$;
MQ1%;_:GT<7T1OTAX_>&'=O"\CG&.16CXE\16?A#P[?ZMJ,Z6NGZ7;27=U,_W
M88HU+NQ]@H)_"OR-TD^(O#^@Z7^W=<QWRW6I?$>2>^M,D^7X2EQIZ+C_`&=O
M'U4]J[<MRY8I2<I6Z+SD]E\[,B<^4_7^N'^*'[37PZ^"=ZEMXO\`'7A+PS=2
M`,D&I:K!;2L#T(1F#8]\8KSK_@HM^UA+^R[^Q#XH^('AZ2"YU.2TAM]#F`$D
M;3W3+'%+CHP4/Y@'0[0.]<#^QU_P2I^''@GX8Z?KOQ$\.Z?\1_B5XEMTU'Q!
MK?B.(:C+)<RJ'>-!+N550G:"!DXR3R`(H82DJ/UC$MI7LDMVUOOLE=?>-R=[
M1/J+P-\0]`^)_A^/5?#>MZ3X@TR4[4N].NX[J%B.HWH2,\],U0^)OQL\'?!?
M3DN_%_BKP]X8MY<^7)JFH16@EQUV[V&[\*\ET;]F#X5_\$^M+^)/Q3\'>'F\
M/AM"DO=2TZSNY$T^06J239CM\^7'(^`"P'88QDY\$_X)S_L3:#^UI\/H/V@/
MCC86WQ"\<?$.22_LK?5E^T6&A6/F,L,$,#?(!A<\@X!4#!W%M(83#.,J[D_9
MJR6BYFVKVWMIU?X:AS/;J?:?PP^./@SXV6$MSX/\5^'?%$$&/-?2]0BNO*ST
MW;&.W\:S/%W[5'PR\`>(KG2-=^(?@C1M5LB%N+.^URVM[B`E0P#([AERI!Y'
M0BN0\&_\$[_A#\-/CQIOQ&\*^$;7PIXDTV":W_XDTC65I=I*NT^=;QD1R;1G
M;E>"<\D#'S-\"?@SX%^,'_!6/]IZ+QOX9\,>(X+&+1'M5UFRAN5@9K4!B@D!
MP2%7)'H*='"X6HZDXRERQC?97OS)6WMUO?\``3E)61]W>#/'^A?$?1QJ'A[6
MM)UZP+;1<Z=>1W4)/IO0D9_&N?\`'/[2_P`.OAAX@?2?$GCWP;X?U2-%E>SU
M'6;>UG5&Y5BCN&P<'!QS7Q9\"O`WA#X3?\%FWT+X&K:6G@^7P;-<>/=.T:3=
MI5C>>8PM\JI,:3$^7\HZ!GP!EA5/X@:#\,=>_P""VOCN/XJP>"9M`7X>6+6P
M\3FW%J+GSH@NSSSM\S87QCG&ZNA952]JTVW'DY]O>WM9K^M+,7M';YGV[X*_
M:>^&WQ)\1PZ/X=\?^"]=U:X5FBLM/UJVN;B4*"S%41RQ``).!P!6;<?MG?""
MTN)(9?BG\.XY8G,<B-XBM`R,#@J1YG!!!!%8'P!^$/[/D?B]M;^&&A_"A]<T
M="K7OAJ*RDN;)959<%X,L@<!ASC(!KP3_@JK^Q7\(_AU^P9\4O$^A?#;P9I'
MB*TL5N8-2M-*ABN8I7N8MSJX7(8[FR?<UST,-A:F)C0ESKF:6RO=OKY;%-R4
M;GU'H'[6WPK\5Z[::9I?Q)\!ZCJ5_*L%K:6VO6LLUQ(W"HB*Y+,>P`S736?Q
M,\.:AXLU/0;?7M'GUS185N-0TZ.\C:ZL8V&5>6('<BD$$%@`<UX-^QG^Q3\(
MM-^!_P`+/%MO\-O!</B>/0-+U-=43281=K=&VB<S"3;NW[B3NSG)KSK]F%!_
MP^P_:0.!D^&]$SQU_<PT/!T).K[)OW(WUMJ^9+]1<S5K]3["\"_$+0?BAX>C
MU?PUK>D^(-*E=HTO--NX[J!F4X90Z$KD'@C/%2^,?&NC_#OPW<ZSK^K:;H>D
M60#7%]?W*6UO`"0H+2.0JY)`&3U(KXN_85B'['/_``4%^+OP'E_T7PWXN;_A
M/_!L9^6,)*=MU!&/]EA@#T@8]Z=_P5!D?]J;]I#X.?LW63&2Q\0:@/%GB\(?
M]7I5H251CV\QED`S_$L?K5?V9'ZTJ7-[C7-S?W;7;]>GJ'/[M^I]8^,OVAO`
M/PZM--G\0>-O">APZS!]IT^34-6@MEO8L*=\1=AO7#+RN1\P]:RM'_;!^$WB
M'5K6PL/B=X`O;Z^F2WMK>#Q!:22W$CD*J(HDRS$D``<DFOD/_@IKHG@^?_@H
ME^R_9>,K?P]_PAZQ:O'?1:N(ETY8A%'M$GF?(%#!,9XR%KWWX7_!;]EKQ!XW
ML?\`A#=!^"-_XCL'%_:+H\>G37D#1,&$R"/+C8VT[AT.*)8*A"A"K+F;DF]$
MK+5K]`YG>Q]"UB^#_B1X>^(4FHIH.NZ1K3:/=-97ZV-Y'<&RG7[T4NPG8X[J
MV"/2MJOSZ_X)/_&/P=\+?&/[1UOXD\5>&?#MQ=_$_4988M2U."T>9-Q&Y1(P
M)&01D=P:Y<-@_:T:E1;QMIWN[%.5FD?=GCCXB^'_`(9:3%?^)-<TC0+&>X2U
MCN-1NX[6*29\[(PSD`NV#A>IQ5?XB?%OPK\(M/M[OQ7XDT'PU:W<GDP3:I?Q
M6<<SX+;5:1@"<`G`[`U\/?\`!:_XY>!_B9^RYX5T[P]XP\*>(+]?'FCSFUT[
M5K>[F"*TH+[$<G`R,G&.16G_`,%R;;3+O3?@%'K263Z._P`2+);\7FW[.;<H
MPE\S=\NS9NW9XQG-=N&RI5/8^T;7.Y=/Y4G^)#J;VZ'U"/VU_@XQQ_PM?X<9
M)P/^*DL^?_(E>FJX=00<@C(([U\T^&_@E^R)XOUZUTS2-!^`.J:G>/LMK2SC
MTR:>=P"V$1<LQP">!VKVSXW_`!9TOX`?!KQ+XRU=EBTOPOILVH3#.W>(T)"#
MW8@*/=A7#B*,.:,**E=_S+[K%IOJ7=$^*7AGQ-XPU/P]IWB'1+_7]%"MJ&FV
M]]%+=V(.,&6)6+IG(^\!U%7_`!1XITSP3X?N]6UG4++2=+L(S-<WEY.L$%N@
MZL[L0JCW)K\I?@'X9\0_L=^(_@;^TYXGFN4G^-NMWUEX_P#-8B.V@U:7SM/<
MCLJ;%8_117W3_P`%4AN_X)U_&`'D?\(Y<?TKMQ.5QIXBG2A*\9.U_-/EE]VZ
M\FB8SNFSW30-?L?%6B6FI:9>6NHZ=?Q+/;75M*LL-Q&PRKHZDAE(.00<&O/Y
M?VT/@_#*R/\`%3X=*Z,593XCM`5(.""/,Z@UE?\`!/@;?V%_A%C_`*%'3?\`
MTF2OG+_@K#^Q5\(OAA_P3_\`B?XE\._#;P9HOB"QM(9[?4;/288;F&1[N$,R
MN%R"0S`GW-8X7"4)XKZM5;UERIJW>VHY2:CS(^K?#O[6?PM\7Z]::7I/Q(\"
M:GJ=_((;6TM=>M9I[AST5$5RS'V`KI]!^)'A[Q3XFU71=,UW2-0UC061=2L;
M:\CEN-/+@E1-&I+1D@'&X#.*\0_9+_8H^$6A?"OX;^+++X:^"[7Q-#HNGZA'
MJD6DPK=)<-;(QE$@7=O)8G.<\FO"OV./BEX6^%O_``4]_:RE\2^(_#_AQ;W4
M-*6!M3U"&S%P5ADW;3(PW8R,XZ9'K5_4:-3VOL'+W%?5+5\R73U%S-6OU/NG
MQKXYT7X;^&KC6?$.KZ9H6D6>WS[[4+E+:WAW,%&Z1R%&20!D]2*I6'Q;\,ZI
MXOAT&VUW3+C6+BU6^BM8YPSRP,-RNN.""O(QVYZ5\?\`_!9C]H/P!X^_X)Q?
M$/2]%\;^#M:U*X2R,5G9:S;7$\NV]@8[41RQP`2<#@`GM7T9\`?@SX=/AKP5
MXS^P?\5#_P`(U86_VCS7QM^RHN=N=N=O&<=*Q>"C#"JO5NFW))6[*+7YCYKR
MLCU:BBBO.+"BBOA/_@M;_P`%#C^S9\+_`/A7/A*_\OQYXRMF%Q/"_P"\T33V
MRKRY_AEEPR1]P`[\%5SUX'!5,77C0I;O\/,F4E%79\A?\%K/^"A7_#2WQ3/P
MX\*7WF>!/!EV1>3POF/6M13*LV1PT4/*KV+[VY`0U[G^Q7^S'K^O_P#!&N/P
MIX>1K77OCMKC)/?!/^0?82SK%+._JJV5K(0.[2*/XJ_*&5/+M"L>%(7:GH#V
MK]M_^"@'Q\3_`()X?\$SO#?A3P]<+:^)M6T>U\*:*\1PT&VV47%TOND88@_W
MY(Z_0\UP_P!5HX;`81:N5_6VMW\VF_0XZ;YG*<C\[O\`@I=^T9HGB3Q'H_P;
M^'!^R_"7X1`Z=81Q/E=7U!<K<7LC#_6'<756/4F5_P".OI+]E/P5?_`;_@AY
MXWU>QL[B?Q9\:;V33='M;="]Q?&[D33K:)%'))42R#V8FOSE^%_PVU'XN?$3
MP_X0T5"^I^)-0@TNT'7:\KA-Q]E!+'V4U^N__!6W]H+1?V%_V2_!GPT\(>7%
MXMGL1IF@RKCS=#LHK?[-->K_`'9C&[1(^,@S2,#\IK7-(>R^KY?05W*5WYVU
M;?J]6_)BIN_--GYI?L>_M/\`B+]@#]IVW\16T4DBZ7<2:3XBTJ.9674+59-L
MT.Y25+HR[D8$C>@YVDY_H/\`AE\2M%^,7P]T?Q3X<OHM2T/7K1+VRN8SQ+&X
MR/H1T(/(((/(K^8N-!$@51@*,`5^@_\`P0S_`."@?_"F?B"OP@\5WNSPMXKN
MB^@W$S?+IFHN>8,]HYST["7'_/0FL^*LF^L4OK5)>_'?S7_`_+Y#P]2SY7L?
M9O\`P6.^)FI+\!=!^$WAF3'B_P".&M0^%[-02#':LRFZE)'10A5&/I*?2N;U
M3]A3]HW5_P!G5_A5-\2O@\?!+Z*-!^Q#P9.&6U$8C7#?:.'``8/C.X;NM?6W
MB'X'>$?%OQ1T/QKJ?A_3K[Q5X9AEM]*U*>/?-IZ2`B01D\+N!()`S[UU=?#4
M\S=&A"E12T;;;2?O=+7OLDOQ.KDNVV?F3X-\)^)OVU_^"/WCKX.2I+-\4_@M
MJ)T)[)FS-<R:?,)+91GKYD"F)?5DKZA_8>_X*,_#O]HSX'Z/->^)M%\/>+]*
MM([/7]%U2[2RN[&[C79+\DA4E"RD@C.`0#A@0/:O"7P.\(^`OB'XB\6:+X?T
M[3/$7BTQ'6;ZWCV2:D8P0C2XX8@$\XSR:X;XS?\`!/?X)_M">)VUKQC\-/"N
MMZO(<RWLEIY<\Y]9'C*ES_O9K>MC\+74J=6+46^96M=-I<RMU3:TU5A*$EJC
M,\0_'7X:_MN:+\3O@_X2\6V&NZQ_PCLUKJ,UBKSVEF+J.2%?](4&)G5B"45B
M1QQUQX=_P2>_;$\/?#[X*6OP.^)&I6'@?XE_"YY='N=.UBX6U^W0+(QBFA9R
M%<;6`P#DA0P^5@:^O_A)\$O"'P$\*)H?@OPUHWAC24;=]FTVT2!';^\VT99O
M=LGWKG?CQ^QO\+/VGI()/'W@3PYXGN+9=D5Q>6H^T1K_`'1*N'V^V[%80Q6%
M4)8>2E[-M-/3F32M?HK.^WIJ/EE\74K6G[;'PNU;XY:1\.--\8Z5K/B_6H)K
MB&RTQS>B)(EW,9I(@R1<`XWL,XX[5\8^#/V0?A_^V!_P5(_:@TKQ]H?]KQ:;
M;Z0UA*ES+!+8O+:!6DC*,!N^5<;@1E1QUK[A^!/[*7PW_9CL9[?P!X*\/>%%
MN^)WL+14FG'4!Y.78>Q)%:_A?X(^$_!7Q(\0^+]*T'3['Q-XL6%=8U&),3Z@
M(EVQ^8>^T<"G1QU+#.I]5YES1LGUOS)WTV5E:UV#BY6YCX]_X)B:U'^Q?\7/
M$7[,7C#3=)TSQ#:/)K'A77;>RCM?^$UTUBS!I&4#S+F(;@<DG"L/^6>3S7CC
MP7\./'/_``6V\>6OQ/L?"&H:#'\.[&6WC\1B`VRW`FB`*>=\OF;"_3G!:ON'
MXC_L_P#@OXN^)O#NM>)/#FF:MK'A*Y^V:-?31_Z1ILN0=T3@AER57(S@X&:Y
M+XQ?L%_!S]H+QK+XC\:_#OPUXEUR:*.![V^M_,E9(P0BYST`)Q]:Z(9I1=:5
M>?,I3C:5OYKK5:K>VW1[:"Y':W87]G_PO\#OAEKMW9_#&'X::1J6M*OVBW\/
M26B3WJQ!F&Y8CN8(&<].,FN$_P""Q'_*-'XM?]@J/_TIAKM?A)_P3\^"OP'\
M>6GBCP=\-O"_AWQ!8I)';W]G;;)HED0HX!SW4D'ZUZ+\3/AEH'QE\":CX8\4
MZ5::YH&KQB*]L;I=T-R@8,`P],J#^%<2Q-*&+A7BY22:;OOH_5]/,JS<;'+_
M`+('_)I?PO\`^Q2TK_TCBKYK_9A_Y37?M'_]BWHG_HF&OLOPUX<L?!WARPTC
M2[6*RTS2K:.SM+:(82WAC4(B*/0*`!]*P]`^!_A+PM\5-<\;Z?H.GVGBWQ+!
M%;:IJD:8N+V*(`1JY[A0!CZ5-+%QBZUU\::7_@2?Z`XWMY'RY_P5T\)7OPQC
M^&O[06@0L=8^#NO1-J8C&&N='NG6&YC8]2!N'T$CFJ?_``2XT^7]I#XX?&#]
MI'48I?*\::HWASPGYR[6AT>S(3<!V\QU7/\`M1-ZU]B^-/!>E?$;PCJ6@Z[I
M]KJNC:Q;O:7MG<IOBN8G!5D8=P0:K_#?X;:#\'_`^G>&O#&E6>B:#I$7DV=C
M:ILAMTR6(4?4D_4FMEF26"^KV]_:_P#<OS6_\"_`7)[USX?_`."G&A>&/$W_
M``4=_9BL/&=OHMUX7N4UE=1AU?R_L3H(D(\WS/DQO"XSW`KZ&^$7P_\`V;OA
M7XYM]2\#V7P@T/Q',ILH+C2'L8;N02$`Q*4.X[B%&T=<"NO^.W[(GPS_`&G+
MO3Y_'_@O0_%<NDQR16;:A#YAMU<J7"\]RJY^@KCO"_\`P3"_9^\%>)M.UG2O
MA-X.L-4TBZCO;*ZBL\26TT;!TD4YX*L`1]*U>.H3PT*,I33BFK*UGJWW7?L'
M*^:Y[Q7YS_\`!+_]F7X=_'?QQ^T5>>-?`_A7Q7=V'Q-U*"VGU73(KN2",L6*
M*74D+N).!W)K]&*Y/X8?`SPC\%KC79?"OA_3M"D\3:@^JZJUJFTWUT_WYG]6
M/K7'A<:Z%&I3C=.5K->3N.4;M,^$_P#@LC^RA\,O@C^S3X6UCP?X`\(>&-6?
MQSI%LUYI>E0VLYB9I"R;T4':2JY'3@5U?_!<2ST_4;#X`V^KI:2Z3<?$FRBO
MDN\?9W@96$@DW<;"A;=GC&<U]A_%[X(>$OCYX;M]'\9:#I_B+3+2]BU&&VO$
MWI'<19\N0#^\N3CZU2^./[-O@3]I;0[+3?'OA?2O%-AITYNK:"_BWI#*5*%@
M,]=K$?C7=ALW471=6[<'*[_Q))6UZ$NGO;J>7^"OA9^RQ\./%ECKGA_3/@EH
MVM:9)YMG>V;:?#<6SD%=R.I!!P2./4UY-_P6#U?5OCWJ/PU_9P\)W4,6M_%3
M43?ZI*X9X[32[,&4O*JD$QM(H.`1GR2,\UZTO_!)W]F]6!'P;\$9!!'^A=#^
M=>LQ_`KP?%\7AX^'A[33XR73AI*:NT>ZYCM`=WDJQ^ZN><#&<FHAC:-*O'$1
ME*;BG;FMO]GJ]$]1\K:L?('[1_[#G[2OQ_\`V>M8\!Z[\1/A'J&@7%HBQ6%E
MX1FM)5:`J\*PR>>1$P9%`;!P.V*RM0_:2F_:?_X(/^-=8U%G_P"$DT;PQ=:!
MKT<G^LCOK7;&Y?\`VG4)(?\`KI7Z`UYW:_LF_#>R\-^,M'A\&Z)#I7Q!N'N_
M$=FD.V'5Y7^^\J@X+-W(QFG2S9.,8UH_#)27*DO\7;=6^X/9]CS/]A']H3P#
MX>_8L^%5E?\`CCP?97EIX5TZ*>"?6;:.6%Q;H"K*7!4@]0>163_P6'U6VUS_
M`():_%&\LKB"\L[K2[66">"021S(UY;E65AD$$<@CK70O_P2>_9PD)W?!SP2
M=W7-GU_6O5/$'[/_`(+\5?!<?#K4?#FF7?@<64.G#19(_P#11;Q;?+BVY^ZN
MQ,?[HK-XG"PQ<,32YG:2DTTN]]-0M)QY65_V8?\`DVKX>?\`8LZ;_P"DL=?%
M?[+'P`\#?'G_`(*<_M61>-O"'ASQ9'IFHZ6]FNK6$=V+4O`X<H'!V[MJYQUV
MBOT"T#0K/PMH5EIFGV\=I8:=`EK;01C"0Q(H5$`]`H`'TKGO!OP-\(_#WQ_X
MD\4Z+H&G:;XA\8/%)K5_#'B;4FC!"&0]]H)Q]:RP^.]DJSC=.:LK=/>3_)#<
M;V\CXP_X*_\`[&_PF^$O_!//X@:]X8^&W@G0-;LDLQ;W^GZ/!;W$&Z\@1MKJ
MH(RK,#ST)K[-^`/_`"0CP5_V`;'_`-)XZM_%?X2>&OCIX"OO"_B_1K+Q!X?U
M+8+JPNTW0S['#KN'LRJ?PK:T;2+;P]I%K864*6UG8PI;P0H,+%&BA54>P``_
M"IK8YU<+&C-MR4F[OLTE^@*-I719HHHKSRQESYAMW\HH)=IV%P2H;MG':OS1
M^,'_``0,\6_'GXHZYXQ\4?&V#4->\0W375U*?#3!5SPL:#[3\L:*%15[*HK]
M,:*[\#F6(P;<L.[-^2?YHF4(R^(_*H_\&V%\PP?B_:D'J/\`A&C_`/)-='XX
M_P"""7CKXFZ-H>G^(_VA+_7;'PQ;M::3#?:(\RZ?$Q!*1[KG(!VKUSPJCH`!
M^F5%>@^)\R;3=35?W8_Y$>PAV/S2^"__``02\6_L_P#Q4T3QGX8^-&GVNO>'
MYS<6<LWA03QABK(P9&N,$%68'H>>"#@UO?M4_P#!%3QQ^V)\9+SQOXN^,>E#
M4[F"*TBM[/PQ(EK9P1@[8XU:Z8@9+,<DDL[&OT/HK/\`UBQ[J>V<US6M?EC>
MW;8/8PM8_*K_`(AL;_\`Z+!;?^$T?_DFC_B&RU`$$?&*!6!!5E\.,&4CD$$7
M.01ZU^JM%;?ZU9G_`,_/_)8_Y"]A3[')_`SPEXD\!_";0]%\6^(8O%FOZ7;+
M;76L):&U.H[>%E>,L^'*@;CNP6R>,X'6445X$Y.4G)]38****D`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
*****`"BBB@#_V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
